Kendall Burnett advises public and private companies’ on all aspects of employment, remuneration, and incentives matters, particularly in the context of corporate transactions.

Ms. Burnett counsels clients on the full spectrum of global employment and incentives matters, including those related to:

  • Cross-border mergers and acquisitions
  • Share-based incentivization, including plan design and administration
  • Public company representation and corporate governance
  • Recruitment and severance

Ms. Burnett draws on substantial experience helping a wide range of global clients — from emerging companies to publicly listed companies — to recruit, retain, and incentivize dynamic workforces. She regularly advises on complex cross-border transactions, resolving legal and tax considerations across different jurisdictions.

Ms. Burnett maintains an active pro bono practice, advising UK charities on employment law issues.

She is a member of the Employment Lawyers Association and Share Plan Lawyers Group.

Ms. Burnett's experience includes advising:

  • Astorg Partners on the acquisitions of:
    • Opus 2, a legal technology provider
    • Xceptor, a data automation platform
  • Astorg and Cinven-led consortium, on their acquisition of LGC, a global leader in the Life Sciences Tools sector
  • Astorg portfolio company, Corsearch, on the acquisition of Incopro, an online brand protection provider
  • Betbull in its strategic combination with the interactive assets of Wynn Resorts to create Wynn Interactive
  • Blackstone and CVC Capital Partners-led consortium on its £2.96 billion offer for Paysafe Group, a leading global provider of end-to-end payment solutions
  • Darktrace on its £1.7 billion initial public offering on the London Stock Exchange
  • Deliveroo Holding on its initial public offering on the London Stock Exchange — advising the joint global coordinators, joint bookrunners, and underwriters
  • Eleusis Holdings on:
    • Its acquisition of Kalypso Treatment Centers, a leading provider of ketamine infusion therapies in the US
    • Its US$446 Million Merger with Silver Spike Acquisition Corp. II
  • ESR Cayman Limited on its US$1.6 billion initial public offering
  • Expedia on its acquisition of a majority stake in SilverRail Technologies
  • Leonard Green & Partners on its acquisition of Pure Gym
  • LivaNova, a medical device company, on its dual listing on the London Stock Exchange and NASDAQ on the closing of the merger between Cyberonics and Sorin S.p.A
  • Quotient Sciences on its acquisition of Arcinova, a UK-based multiservice contract development and manufacturing organization
  • The Carlyle Group and The Nature’s Bounty Co. on the £1.77 billion sale of Holland & Barrett, one of Europe’s largest health and wellness retailers
  • The Carlyle Group on its US$4.15 billion acquisition from Johnson & Johnson of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases
  • The Cooper Companies on its US$1.256 billion acquisition of Sauflon Pharmaceuticals, a UK-based manufacturer and distributor of contact lenses and contact solutions
  • The sellers on the disposal of Method and Ecover to US private company SC Johnson
  • TI Fluid Systems on its £1.3 billion initial public offering on the London Stock Exchange

Bar Qualification

  • England and Wales (Registered Foreign Lawyer)
  • Scotland (Solicitor)


  • Diploma in Legal Practice, Glasgow Graduate School of Law, 2008
  • LLB (First Class Honours), University of Glasgow, 2007